A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Clinical trial NCT04294160 · TERMINATED
Trial details
- NCT number
- NCT04294160
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2024-09-25
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.